Amid the relentless chaos in Washington — tariffs, trade war, terminally rising deficits — at least one sensible idea has recently emerged: The federal government wants t...
Big business lobbyists are winning an obscure — but hugely consequential — battle over the future of the judicial system. If these lobbyists get their way, small business...
The wise minds at Moody’s Investors Service finally acknowledged last week what the other two main credit rating agencies did years ago: America has a debt problem. Now i...
Last month, the security systems designed to protect Gov. Josh Shapiro, his family and the governor’s official residence in Harrisburg failed.
A man armed with Molotov co...
Judging by public statements, prospects for a new deal to contain Iran’s nuclear program may be improving. A top adviser to Supreme Leader Ayatollah Ali Khamenei has aff...
I have my mother’s eyes, but my father’s sense of humor. While I’ve inherited many genetic traits from the paternal side of my family, the one I treasure most is the abil...
If you watch HBO’s “The Last of Us,” you see how a pandemic didn’t destroy the world — failure to communicate did. Trust collapsed. Institutions froze. And the people pai...
As one of the first acts of his second term, President Donald Trump suspended the U.S. refugee program, not to be restarted “until such time as the further entry into the...
As a pediatric resident in Texas, I have seen how important Medicaid is for my patients and their ability to access the care they need to thrive, and what can happen when...
The price of Wegovy, Novo Nordisk’s blockbuster weight-loss drug, is $1,349 a month in the U.S.; in Germany, it’s $328. The U.S. price for Keytruda, a cancer treatment, i...
